The GreensKeeper Value Fund finished the year 2024 +23.6% net of fees and expenses. Click here to read the full fund letter.

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech ...

Unum Group is a buy with strong market presence, growth potential, and undervaluation contributing to its resilience and ...

Since it has a market capitalisation of US$723m, Relay Therapeutics' US$283m in cash burn equates to about 39% of its market value. That's not insignificant, and if the company had to sell enough ...

FSG are in the process of ballsing it up for Liverpool again but what would Elon Musk do in his first ten days as owner? Also ...

While Questor is unashamedly bullish about the long-term prospects for the UK economy, investment opportunities also abound ...

When it comes to the bumper $62bn takeover of UK drugs group Shire by its larger Japanese rival Takeda Pharmaceutical (whose ...

Strategic framework wins have set Galliford Try on course to beat last year’s trading performance. In a financial update ...

After an eventful 2024, we aren't expecting an overly transformative year ahead for M&A in the telecom space. We also don't ...

Recessions are particularly bad news for office landlords and shopping centres. Some sub-sectors, such as student accommodation, can slip under the radar of high interest rates to a degree — a bank ...

China has two broad options: retaliate or seek to de-escalate tensions. Each path comes with distinct implications for ...

Financial Highlights for the Second Quarter of Fiscal 2025 Biomerica continued to deliver improved financial performance, ...